Literature DB >> 6317125

Hypothalamic regulation of the cardiovascular and respiratory systems: role of specific opiate receptors.

A I Faden, G Feuerstein.   

Abstract

Experiments were designed to evaluate the role of mu and delta opiate receptors in central cardiovascular control in the hypothalamic nucleus preopticus medialis of rats anaesthetized with pentobarbitone. The highly selective mu opiate receptor agonist D-Ala2-MePhe4-Gly5-ol-enkephalin was extremely potent in eliciting hypotension and bradypnoea; tachycardia was elicited by a low dose (0.064 nmol), but not by higher doses (0.64-6.4 nmol). Other selective mu receptor agonists (morphine sulphate, morphiceptin) caused tachycardia at lower doses (0.64, 6.4 nmol), hypotension and bradypnoea after the highest dose (64 nmol). The relatively selective delta receptor agonist D-Ala2-D-Leu5-enkephalin caused profound bradypnoea and hypotension at the high dose (64 nmol), tachycardia after the lowest dose (0.64 nmol), but bradycardia was found during the hypotension induced by the high dose (64 nmol). All of the opiate/opioid effects were reversed by naloxone (0.5 mg kg-1, i.v.). It is concluded that mu receptors may mediate the cardiovascular and respiratory effects of opiates and opioid peptides in the nucleus preopticus medialis of the rat.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6317125      PMCID: PMC2044938          DOI: 10.1111/j.1476-5381.1983.tb10547.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  26 in total

1.  Opioid peptide enkephalin: immunohistochemical mapping in rat central nervous system.

Authors:  R Simantov; M J Kuhar; G R Uhl; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

2.  Cardiovascular effects of morphine and opioid peptides following intracisternal administration in chloralose-anesthetized rats.

Authors:  P Bolme; K Fuxe; L F Agnati; R Bradley; J Smythies
Journal:  Eur J Pharmacol       Date:  1978-04-01       Impact factor: 4.432

3.  Naloxone acts at central opiate receptors to reverse hypotension, hypothermia and hypoventilation in spinal shock.

Authors:  J W Holaday; A I Faden
Journal:  Brain Res       Date:  1980-05-05       Impact factor: 3.252

4.  Ventriculocisternal administration of naloxone protects against severe hypotension during endotoxin shock.

Authors:  H F Janssen; L O Lutherer
Journal:  Brain Res       Date:  1980-08-04       Impact factor: 3.252

5.  Properties and localization of beta-endorphin receptor in rat brain.

Authors:  P Y Law; H H Loh; C H Li
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

6.  Antagonism by naloxone of narcotic-induced respiratory depression and analgesia.

Authors:  K L McGilliard; A E Takemori
Journal:  J Pharmacol Exp Ther       Date:  1978-11       Impact factor: 4.030

7.  Central cardiovascular effects of morphinomimetic peptides in dogs.

Authors:  M Laubie; H Schmitt; M Vincent; G Remond
Journal:  Eur J Pharmacol       Date:  1977-11-01       Impact factor: 4.432

8.  Naloxone reverses the antihypertensive effect of clonidine.

Authors:  C Farsang; G Kunos
Journal:  Br J Pharmacol       Date:  1979-10       Impact factor: 8.739

9.  Endogenous opioid peptides: multiple agonists and receptors.

Authors:  J A Lord; A A Waterfield; J Hughes; H W Kosterlitz
Journal:  Nature       Date:  1977-06-09       Impact factor: 49.962

10.  Effects of changes in the structure of enkephalins and of narcotic analgesic drugs on their interactions with mu- and delta-receptors.

Authors:  H W Kosterlitz; J A Lord; S J Paterson; A A Waterfield
Journal:  Br J Pharmacol       Date:  1980-02       Impact factor: 8.739

View more
  5 in total

1.  Renal effects of TAPP, a highly selective mu-opioid agonist.

Authors:  J Gutkowska; P W Schiller
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

2.  Inhibition of elevated arginine vasopressin secretion in response to osmotic stimulation and acute haemorrhage by U-62066E, a kappa-opioid receptor agonist.

Authors:  K Yamada; M Nakano; S Yoshida
Journal:  Br J Pharmacol       Date:  1990-02       Impact factor: 8.739

3.  The effects of alfentanil and selected narcotic analgesics on the rate of action potential discharge of medullary respiratory neurones in anaesthetized rats.

Authors:  K C Fone; H Wilson
Journal:  Br J Pharmacol       Date:  1986-09       Impact factor: 8.739

4.  Hypotensive effect of taurine. Possible involvement of the sympathetic nervous system and endogenous opiates.

Authors:  T Fujita; Y Sato
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

5.  Heart Rate Variability as an Indicator of Chronic Stress Caused by Lameness in Dairy Cows.

Authors:  Levente Kovács; Fruzsina Luca Kézér; Viktor Jurkovich; Margit Kulcsár-Huszenicza; János Tőzsér
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.